| Cheplapharm Schweiz GmbH - Ebrantil 50 mg, Injektionslösung |
| 44486 | | 02 | | Ebrantil 50 mg | | Injektionslösung | | C02CA06 | | Urapidil | | 21.07.1983 | | |
|
| Composition |
| urapidilum 50 mg ut urapidili hydrochloridum 50.47 mg, propylenglycolum 1000 mg, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 10 ml, natrium 3.814 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Urapidil | 50mg / 10ml |
| | | | Inactive agents | Dose |
|---|
| Disodium Phosphate Dihydrate | | | Sodium Dihydrogenophosphate Dihydrate | | | Propylenglycol | 1000mg / 10ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 032 | 5 1 ampoule(s) à 10 ml | | 101.00 | B | | No |
|
